Bioventus Inc.

BVSNASDAQHealthcare● Active

$9.03

$-0.01(-0.07%)

Market Cap$612042640

P/E Ratio—

52W High$11.249

52W Low$5.81

Avg Volume552K

Open$9.09

Beta0.67

Overview

Bioventus Inc. (BVS) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

BVS · net income · updated Jun 8, 2026

Core profitability metrics

BVS · net income · margin · TTM · CAGR

Net income was $22.7M for FY2025 (fiscal year ending 2025-12-31), up 167.8% year-over-year. Net profit margin was 4.0%. Based on available data, Bioventus Inc. has been profitable since at least 2019.

FY2025 Net Income$22.7M▲ +167.8% YoY

Trailing 12M (TTM)$28.5Mtrailing 4 quarters sum

Net Profit Margin4.0%$22.7M ÷ $568.1M

YoY Change+167.8%—

5-Year CAGR+6.7%FY2020 → FY2025

FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /income-statement · US GAAP · USDUpdated: Jun 8, 2026

Annual net income history

Net Income (bars) · Net Profit Margin % (line)

Net IncomeNet LossNet Margin %★ First Profit: 2019

▸ FMP /income-statement · Annual · BVS net income history · BVS profit margin

Annual net income data

BVS · net income history · annual / quarterly

Fiscal YearNet IncomeYoY ChangeNet MarginRevenue

FY2025$22.7M▲ +167.8%4.0%$568.1M

FY2024Loss−$33.5M▲ +78.5%-5.8%$573.3M

FY2023Loss−$156.2M▲ +1.6%-30.5%$512.3M

FY2022Loss−$158.7M▼ 919.1%-31.0%$512.1M

FY2021$19.4M▲ +18.1%4.5%$430.9M

Net income vs peers (Healthcare)

BVS vs peers · net income

#CompanyNet IncomeYoYNet MarginRelative

Bioventus Inc.YOU

BVS

$22.7M+167.8%4.0%

Eli Lilly and Company

LLY

$20.64B+94.9%31.7%

77%

UnitedHealth Group Incorporated

Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

Bioventus Inc. (BVS) reported net income of $22.7M for FY2025 (fiscal year ending 2025-12-31), up 167.8% year-over-year. The net profit margin was 4.0% — meaning the company kept $0.04 of every dollar of revenue as profit.

Based on available data, Bioventus Inc. has been profitable since at least 2019. Net income reached a peak of $22.7M in FY2025. Data available for 13 fiscal years.

Bioventus Inc.'s net profit margin was 4.0% for FY2025, based on the latest annual results.

Investors sometimes search for "Bioventus Inc. net worth" — the company's market capitalization is a separate figure from BVS net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Revenue Financial statements Earnings Forecast Price history Market cap Free cash flow

Frequently asked questions

BVS net income · 5 questions

Bioventus Inc. is profitable. The company reported net income of $22.7M for FY2025, a net profit margin of 4.0%. Net income was up 167.8% year-over-year. Based on available data, Bioventus Inc. has been profitable since at least 2019.

is BVS profitabledoes BVS make a profitBVS profitabilityBVS profitable company

▸ Source: FMP /income-statement · GAAP · Bioventus Inc. · Bioventus Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026